The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze

GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212‐2 2 mg/kg and tested on the Elevated Plus‐Maze.[Image: see text]

Detalles Bibliográficos
Autores principales: Cassar, Daniel, Radic, Manuela, Casarrubea, Maurizio, Crunelli, Vincenzo, Di Giovanni, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253729/
https://www.ncbi.nlm.nih.gov/pubmed/35470960
http://dx.doi.org/10.1111/cns.13848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253729/
https://www.ncbi.nlm.nih.gov/pubmed/35470960
http://dx.doi.org/10.1111/cns.13848

Ejemplares similares